Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga.
about
Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results.Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.Use of BRCA Mutation Test in the U.S., 2004-2014.
P2860
Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Commercial Opportunities and E ...... isit the Myriad Genetics Saga.
@en
Commercial Opportunities and E ...... isit the Myriad Genetics Saga.
@nl
type
label
Commercial Opportunities and E ...... isit the Myriad Genetics Saga.
@en
Commercial Opportunities and E ...... isit the Myriad Genetics Saga.
@nl
prefLabel
Commercial Opportunities and E ...... isit the Myriad Genetics Saga.
@en
Commercial Opportunities and E ...... isit the Myriad Genetics Saga.
@nl
P2860
P1476
Commercial Opportunities and E ...... isit the Myriad Genetics Saga.
@en
P2093
P2860
P304
P356
10.2174/1875692111311020003
P50
P577
2013-06-01T00:00:00Z